More tools:Markets·Screener·Research·Chat

SEAPORT THERAPEUTICS INC (SPTX) Financial Statements

SEAPORT THERAPEUTICS INC
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01MBY86L8
US
24.06▲ 5.89 (32.42%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)—
EBITDA—
Diluted EPS (TTM)—
EBITDA Margin—
Net Debt—
Trading Information
Previous Close18.17
Day's Range16.91 – 18.28
52-Week Range14.85 – 23.00
Volume1.3M
Avg Volume261.3K
Share Statistics
Shares Outstanding
Employees—
ExchangeUS
Listed—
Share count as of July 27, 2026
Loading Income Statement…
Key questions about SEAPORT THERAPEUTICS INC (SPTX)
What is SEAPORT THERAPEUTICS INC's Market Cap?
SEAPORT THERAPEUTICS INC's Market Cap is $1.3B, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Operating expenses:
Research and development (including non-cash stock-based compensation expense of $0.9 million and $0.6 million for three months ended June 30, 2026 and 2025, respectively and $1.8 million and $1.1 million for six months ended June 30, 2026 and 2025 respectively)
General and administrative (including non-cash stock-based compensation expense of $36.0 million and $1.2 million for the three months ended June 30, 2026 and 2025, respectively and $37.6 million and $2.3 million for six months ended June 30, 2026 and 2025 respectively
Total operating expenses
Loss from operations
Other income (expense), net
Interest income, net
Research and development tax credit
Other expense, net
Total other income, net
Loss before income taxes
Income tax provision
Net loss
Net loss per share, basic
Net loss per share, diluted